ATORVALIQ

Peak

atorvaliq

NDAORALSUSPENSION
Approved
Feb 2023
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. In animal models, atorvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA…

Loss of Exclusivity

LOE Date
Jun 7, 2037
137 months away
Patent Expiry
Jun 7, 2037

Patent Records (5)

Patent #ExpiryTypeUse Code
11369567
Jun 7, 2037
Product
11654106
Jun 7, 2037
Product
U-3613
11925704
Jun 7, 2037
Product
U-3853
12168069
Jun 7, 2037
Product
12370136
Jun 7, 2037
Product